Interleukin-17 Can Be the Target of Novel Treatment Strategies for Particulate Matter-Induced Allergic Diseases

Allergy Asthma Immunol Res. 2022 Jan;14(1):5-7. doi: 10.4168/aair.2022.14.1.5.
No abstract available

Publication types

  • Editorial